Centessa Pharmaceuticals +20% After Study Results

Benzinga ·  Feb 9 15:39

$Centessa Pharmaceuticals (CNTA.US)$ jumped 20% after the ompany presented results from a year long study on the treatment of hemophilia

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment